Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  SHENZHEN STOCK EXCHANGE  >  BGI Genomics Co., Ltd.    300676   CNE100003449

BGI GENOMICS CO., LTD.

(300676)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shenzhen Stock Exchange
03/01/2021 03/02/2021 03/03/2021 03/04/2021 03/05/2021 Date
139.43 136.33 135.09 129.36 130.63 Last
3942880 4033089 3942577 6235077 3881721 Volume
+1.04% -2.22% -0.91% -4.24% +0.98% Change
Financials
Sales 2020 8 985 M 1 383 M 1 383 M
Net income 2020 3 530 M 543 M 543 M
Net Debt 2020 - - -
P/E ratio 2020 14,8x
Yield 2020 0,15%
Sales 2021 5 359 M 825 M 825 M
Net income 2021 1 600 M 246 M 246 M
Net Debt 2021 - - -
P/E ratio 2021 32,7x
Yield 2021 0,06%
Capitalization 53 547 M 8 244 M 8 243 M
Capi. / Sales 2020 5,96x
Capi. / Sales 2021 9,99x
Nbr of Employees -
Free-Float 100,0%
More Financials
Company
BGI Genomics Co., Ltd. is a China-based company principally engaged in the diagnosis and research of genomics. The Company's main products and services include reproductive health basic research and clinical application services, basic science research services (genome sequencing, bioinformatics analysis and other multithreaded solutions), complex disease basic research and clinical application services, as well as... 
More about the company
Notations Surperformance© of BGI Genomics Co., Ltd.
Trading Rating : - Investor Rating :
More Ratings
All news about BGI GENOMICS CO., LTD.
02/22MARKET CHATTER : Chinese Government Invests in Gene Company BGI Genomics
MT
02/21BGI GENOMICS  : Chinese state fund invests in gene firm BGI
RE
02/10China's coronavirus anxiety super-charges testing business in holiday season
RE
01/30BGI GENOMICS  : China gene firm providing worldwide COVID tests worked with Chin..
RE
2020China's BGI wins 1.5 million coronavirus test kit order from Ethiopia
RE
2020China's BGI wins 1.5 mln coronavirus test kit order from Ethiopia
RE
2020BGI GENOMICS  : WHO says it is in talks with China's BGI on test kit after Swedi..
RE
2020BGI GENOMICS  : China's BGI defends COVID-19 test kit after Swedish criticism
RE
2020BGI GENOMICS CO., LTD.  : half-yearly earnings release
2020SPECIAL REPORT : COVID opens new doors for China's gene giant
RE
2020BGI GENOMICS  : Chinese genetics company BGI denies U.S. human rights accusation..
RE
2020U.S. adds 11 firms to economic blacklist over China's treatment of Uighurs
RE
2020U.S. adds 11 firms to economic blacklist over China's treatment of Uighurs
RE
2020BGI GENOMICS  : China's BGI forecasts 700% jump in first-half profit due to COVI..
RE
2020China's BGI gets Australian foothold through mass coronavirus test delivery
RE
More news
News in other languages on BGI GENOMICS CO., LTD.
2020CORONAVIRUS : le point sur la pandémie
2020BGI GENOMICS CO., LTD.  : Veröffentlichung des Halbjahresergebnisses
2020BGI GENOMICS CO., LTD.  : publication des résultats semestriels
More news
Chart BGI GENOMICS CO., LTD.
Duration : Period :
BGI Genomics Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BGI GENOMICS CO., LTD.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Average target price
Last Close Price 130,63 
Spread / Highest target -
Spread / Average Target -
Spread / Lowest Target -
EPS Revisions
Managers and Directors
NameTitle
Ye Yin General Manager & Director
Yi Qing Chen Chief Financial Officer
Jian Wang Chairman
Song Gang Li Chairman-Supervisory Board
Chang Jian Jiang Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
BGI GENOMICS CO., LTD.1.61%8 244
EXACT SCIENCES CORPORATION-4.47%20 568
GUARDANT HEALTH, INC.3.31%13 585
INVITAE CORPORATION-18.34%6 714
ADAPTIVE BIOTECHNOLOGIES CORPORATION-26.13%5 879
IOVANCE BIOTHERAPEUTICS, INC.-31.53%4 756